https://www.news-medical.net/news/20230118/The-efficacy-of-low-dose-fluvoxamine-compared-with-placebo-for-treating-mild-to-moderate-COVID-19-in-the-US.aspx
Researchers evaluated the efficacy of low-dosage fluvoxamine (50 mg two times a day) over 10 days in the management of mild and moderate-SARS-CoV-2 infections in the US.
Create an account or login to join the discussion